Requirements

All of it, confirmed on 18/09/2026 and shaped by OQ-05 and OQ-18. A pharma user first meets an anonymous card: profession, country and topic, with no name, no employer and no question text. The profile proper opens only after the expert accepts a contact request, and then carries name, affiliation, specialty, the topic signal summary, the fit score, papers and trials. Optional fields appear when available: country, congress talks, guideline and society roles, grants, KOL type and last-updated dates. Every profile carries a completion score the customer can see, which sorts and scores nothing (OQ-18, NP-06). The expert may sign in with ORCID to fill the optional fields, see the topics flagged for them, and withdraw entirely (NP-06, FD-03). The 12 researchers of the August 2026 note appear nowhere (OQ-33).

Still held. Nothing. Two rules travel with the profile: a withdrawal deletes the expert's stored signals, recalculates the affected totals and re-applies the minimums (OQ-34, FD-03), and tumour-board membership appears only inside a revealed profile, never on a card, an export or an API answer that precedes an acceptance (NP-02).

Released by OQ-05, OQ-18, OQ-33, NP-02, NP-06, FD-03.

All of it, including the retroactive half that used to be held. A withdrawal deletes the contributor's stored signal events, recalculates every affected aggregate, and re-applies the suppression rules to every affected view, so a total that falls below 8 contributors or 3 institutions without them stops being shown (OQ-34). An expert may also withdraw entirely from the claim-your-profile page, which removes them from every list, card, trend and future processing, and the withdrawal is recorded with its time and the wording shown, because it is an objection under Article 21 (FD-03).

Still held. Nothing.

Released by OQ-34, FD-03.